How to buy peptides: clinics, compounding pharmacies and vendors

The route is decided by the compound's regulatory status, not by preference. An approved drug can be prescribed and dispensed as the branded product. A compound on the right FDA list can be made by a compounding pharmacy on prescription. Everything else is sold only as a research chemical, and buying it means accepting that no pharmacy, clinic or regulator stands behind the vial.

The table below sorts the common compounds by the routes that actually exist for them in the US as of October 2026. Other countries differ: in the UK and Australia the research market is the main route for nearly everything that is not an approved medicine, and both have tighter rules on importing injectables.

For semaglutide, tirzepatide, tesamorelin and PT-141, the cleanest path is a prescription for the branded product. A telehealth visit or a clinic appointment produces a prescription, a licensed pharmacy fills it, and the product is the one studied in the trials with the dose, device and labeling that go with it. This costs the most, and insurance coverage for weight management is inconsistent, which is what pushed so many people toward compounded versions.

HGH is the special case. It is approved, but US federal law specifically restricts distributing growth hormone for anything other than approved medical uses, so a legitimate prescription needs a diagnosed indication. Grey market HGH is also the most counterfeited product in the category, which is why the compound page says pharmacy pens are the only reliable source.

Compounding pharmacies make drugs to order. A 503A pharmacy fills patient-specific prescriptions and answers mostly to state boards; a 503B outsourcing facility can make larger batches without individual prescriptions but registers with the FDA and follows manufacturing standards closer to a drug company's. Whether a peptide can be compounded at all depends on separate FDA eligibility lists, and that is where 2026 got complicated.

For the GLP-1 drugs, compounding took off during the 2022 to 2024 shortages. Once the shortages were declared over, the legal basis narrowed. On April 30, 2026 the FDA proposed removing semaglutide, tirzepatide and liraglutide from the 503B bulks list. The comment period closed June 29, 2026, and as of October no final decision has been reported. If finalized, outsourcing facilities could no longer compound these from bulk powder outside a shortage, which would push most compounded GLP-1 supply back to patient-specific 503A prescriptions or off the legitimate market entirely.

For BPC-157, the direction is the opposite but the result is the same for now. The FDA placed it in Category 2 in 2023, barring compounding. In April 2026 it was removed from Category 2 along with eleven other peptides, which is not Category 1 and does not clear it for compounding. In late July 2026 an advisory committee voted 8 to 6 to recommend adding it to the 503A bulks list. That vote is non-binding, rulemaking is pending, and until it finishes no US pharmacy can legally compound BPC-157. The full timeline is on its own page.

Research vendors sell peptides as laboratory reagents, labeled for research use only and not for human consumption. That framing is what keeps them on the right side of drug law: they are not selling a drug, so drug approval does not apply. The moment a vendor markets the product for human use, with weight loss claims or dosing instructions, it becomes an unapproved drug in the FDA's eyes and the vendor is exposed. This is why serious vendors are careful about their copy and why a site that promises you will lose 30 pounds is a warning sign on its own.

For the buyer, the picture is different. Buying a research chemical is not a crime in the US for compounds that are not controlled substances, and none of the common peptides are scheduled. Possession for personal use is generally not prosecuted. What you lose is every protection a drug buyer has: no adverse event reporting, no recall system, no guarantee of sterility, and no recourse beyond a chargeback if the vial is wrong. Importing injectables into countries like Australia or the UK can also trigger customs seizure, and vendors shipping domestically within each country exist partly for that reason.

Approved molecules sold this way, such as grey market semaglutide powder, occupy an odd middle ground. The pharmacology is well understood, but the product has nothing to do with the approved supply chain, and reconstituting and dosing it from a vial is on you. The semaglutide dosage chart and the calculator exist because of how many people are in exactly that position.

These are the checks the site applies before listing anyone on the vendor page, written out so you can run them on a vendor that is not listed. A vendor needs to pass all six, and stays listed only while that remains true.

Purity is the share of the sample that is the intended peptide rather than fragments and synthesis leftovers, measured by HPLC. It is a ratio. A vial can be 99.5 percent pure and contain 6 mg of peptide when the label says 10, because the fill weight is a separate measurement that most grey market COAs never report. It also says nothing about identity: HPLC shows a clean peak, and only mass spectrometry confirms that peak has the molecular weight of the peptide you paid for.

Neither number covers sterility or endotoxin. Endotoxin is tested with an LAL assay and reported in endotoxin units; it matters because endotoxin survives sterile filtration and causes fever and inflammation when injected. Most research COAs skip it. A good certificate shows HPLC purity, mass spec identity, a lot number matching your vial, a named lab, and ideally quantity and endotoxin. How to read a COA goes through each line.

Research vendors have trouble keeping card processors because of what they sell, so unusual payment options are common and not automatically a problem. Crypto, Zelle and bank transfer are normal in this market. The red flag is a vendor that accepts only irreversible payment and has no track record, because you have no chargeback and no reputation to lean on if the order never arrives. An established vendor with a crypto discount is a different situation from an anonymous site that only takes gift cards.

Shipping tells you how much a vendor understands the product. Lyophilized peptides tolerate a few days at room temperature in transit, so a cold pack for powder is a courtesy rather than a necessity. Reconstituted or pre-mixed products do need cold chain, and a pre-mixed GLP-1 vial that arrives warm has been quietly degrading the whole way. Domestic shipping avoids customs, which matters for injectables in several countries and is why the vendor list is sorted by where the vendor ships from.

On arrival, check that the vial is sealed, the label names the compound and amount, and the lot number matches a certificate you can find. Loose powder, missing labels or a vial that looks half full compared with the last order are reasons to stop and ask before reconstituting anything. Then store it properly; how long peptides last covers that.